definiens: shall mean any LICENSED PRODUCT that ( a ) is manufactured by a [COMPANY] sublicensee ( includ ing indirect sublicensees that have been granted su blicenses through the Medicines Patent Pool Foundation under direct license from [COMPANY] ) ; and ( b ) is sold in an ACCESS COUNTRY at a price that is no higher than the then current price for ACCESS PRODUCT in such country ; a nd ( c ) bears, or is otherwise marketed using, a tradem ark or tradename that is distinct from any trademar k or trade name used by [COMPANY] or its AFFILIATES in connection with their marketing of such LICENSED PRODUCT . For the avoidance of doubt, [COMPANY] will have no obligat ion to pay IOCB / REGA any royalty or other amount wi th respect to payments received by [COMPANY] or its AFFIL IATES from its sublicensees ( such as a license fee ) as consideration for [COMPANY] ’s or its AFFILIATES ’ grant to such sublicensees of the right to manufacture o r sell GENERIC PRODUCT